| 000 | 02974cam a2200445Mi 4500 | ||
|---|---|---|---|
| 999 |
_c9046 _d9046 |
||
| 001 | 811378285 | ||
| 003 | OCoLC | ||
| 005 | 20170328104020.0 | ||
| 006 | m o d | ||
| 007 | cr mn||||||||| | ||
| 008 | 120530s2013 stka ob 001 0 eng d | ||
| 020 | _a9780702053160 (electronic bk.) | ||
| 020 | _a0702053163 (electronic bk.) | ||
| 020 | _z9780702042997 | ||
| 020 | _z0702042994 | ||
| 035 | _a.b71556278 | ||
| 040 |
_aE7B _cE7B _dOCLCO _dYDXCP _dOCLCA _dUtOrBLW _erda |
||
| 049 | _aOSUU | ||
| 050 | 1 | 4 |
_aRM301.25 _b.D783 2013eb |
| 082 | 0 | 4 |
_a615.19 _223 _bD |
| 245 | 0 | 0 |
_aDrug discovery and development : _btechnology in transition / _cedited by R.G. Hill, H.P. Rang ; foreword by Patrick Vallance. |
| 250 | _asecond edition | ||
| 264 | 1 |
_aEdinburgh ; _aNew York : _bElsevier/Churchill Livingstone, _c[2013] |
|
| 264 | 4 | _cc2013. | |
| 300 |
_axiv, 345 pages : _bill. (chiefly color) ; _c24 cm |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 500 | _apharmacy bookfair2015 | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aThe development of the pharmaceutical industry / H.P. Rang -- The nature of disease and the purpose of therapy / H.P. Rang, R.G. Hill -- Therapeutic modalities / H.P. Rang, H. LeVine, R.G. Hill -- The drug discovery process : general principles and some case histories / H.P. Rang, R.G. Hill -- Choosing the project / H.P. Rang, R.G. Hill -- Choosing the target / H.P. Rang, R.G. Hill -- The role of information, bioinformatics and genomics / B. Robson, R. McBurney -- High-throughput screening / D. Cronk -- The role of medicinal chemistry in the drug discovery process / P. Beswick, A. Naylor -- Metabolism and pharmacokinetic optimization strategies in drug discovery / P. Ballard ... [et al.] -- Pharmacology : its role in drug discovery / H.P. Rang -- Biopharmaceuticals / H. LeVine -- Scaffolds : small globular proteins as antibody substitutes / D. Grabulovski, J. Bertschinger -- Drug development : introduction / H.P. Rang, R.G. Hill -- Assessing drug safety / H.P. Rang, R.G. Hill -- Pharmaceutical development / T. Lundqvist, S. Bredenberg -- Clinical development : present and future / C. Keywood -- Clinical imaging in drug development / P.M. Matthews -- Intellectual property in drug discovery and development / P. Grubb -- Regulatory affairs / I. Hogglof, A. Holmgren -- The role of pharmaceutical marketing / V.L. Lawton -- Drug discovery and development : facts and figures / H.P. Rang, R.G. Hill. | |
| 588 | _aDescription based on print version record. | ||
| 650 | 0 |
_aDrugs _xDesign. |
|
| 650 | 0 | _aDrug development. | |
| 655 | 0 | _aElectronic books. | |
| 700 | 1 |
_aHill, R. G. _q(Raymond G.), _eeditor. |
|
| 700 | 1 |
_aRang, H. P. _eeditor. |
|
| 776 | 0 | 8 |
_iPrint version: _tDrug discovery and development. _b2nd ed. _dEdinburgh ; New York : Elsevier, 2013 _z9780702042997 _w(DLC) 2012022101 _w(OCoLC)748336518. |
| 942 |
_2ddc _cBK |
||